These limits of the BTNX NTS are highly related, as we identified e.g. etodesnitazene to possess an identical in vitro potency and efficacy as fentanyl [7, 13] and as it may likely give PWUD a false perception of protection. Additionally, the detectability of nitazene analogues in drug samples may be impacted by solubility issues, as highlighted fr